| scholarly article | Q13442814 |
| P50 | author | Paolo Gallo | Q82114706 |
| Dario Seppi | Q86981385 | ||
| P2093 | author name string | Matteo Atzori | |
| Alice Favaretto | |||
| Paola Perini | |||
| Francesca Rinaldi | |||
| P2860 | cites work | Grey matter volume in a large cohort of MS patients: relation to MRI parameters and disability | Q57655312 |
| Progression in disability and regional grey matter atrophy in relapsing–remitting multiple sclerosis | Q60242775 | ||
| Cortical lesions in multiple sclerosis | Q63185098 | ||
| Effect of disease-modifying drugs on cortical lesions and atrophy in relapsing-remitting multiple sclerosis | Q83178639 | ||
| The predictive value of gray matter atrophy in clinically isolated syndromes | Q84197250 | ||
| Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis | Q22252943 | ||
| Measurement and clinical effect of grey matter pathology in multiple sclerosis | Q30577548 | ||
| Cortical lesions in multiple sclerosis: combined postmortem MR imaging and histopathology. | Q30984640 | ||
| The measurement and clinical relevance of brain atrophy in multiple sclerosis | Q31030179 | ||
| Magnetic resonance imaging in monitoring the treatment of multiple sclerosis: concerted action guidelines | Q33437936 | ||
| A case of multiple sclerosis presenting with inflammatory cortical demyelination | Q34999357 | ||
| Multiple sclerosis diagnostic criteria: three years later | Q36054780 | ||
| Cognitive reserve and cortical atrophy in multiple sclerosis: a longitudinal study. | Q43866034 | ||
| Low degree of cortical pathology is associated with benign course of multiple sclerosis. | Q44584762 | ||
| The changing clinical course of multiple sclerosis: a matter of gray matter | Q46292409 | ||
| Extent of cerebellum, subcortical and cortical atrophy in patients with MS: a case-control study | Q46309628 | ||
| Evidence of early cortical atrophy in MS: relevance to white matter changes and disability | Q47983445 | ||
| Cortical atrophy is relevant in multiple sclerosis at clinical onset. | Q48241189 | ||
| Cortical lesions and atrophy associated with cognitive impairment in relapsing-remitting multiple sclerosis | Q48459611 | ||
| Accumulation of cortical lesions in MS: relation with cognitive impairment | Q48618943 | ||
| Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions | Q48791086 | ||
| Gray and white matter volume changes in early RRMS: a 2-year longitudinal study. | Q48958924 | ||
| P275 | copyright license | Creative Commons Attribution 3.0 Unported | Q14947546 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P921 | main subject | multiple sclerosis | Q8277 |
| relapsing-remitting multiple sclerosis | Q18555066 | ||
| P304 | page(s) | 369348 | |
| P577 | publication date | 2015-02-23 | |
| P1433 | published in | Multiple Sclerosis International | Q26853855 |
| P1476 | title | Disease-modifying drugs reduce cortical lesion accumulation and atrophy progression in relapsing-remitting multiple sclerosis: results from a 48-month extension study | |
| P478 | volume | 2015 |
| Q36171258 | The relevance of cortical lesions in patients with multiple sclerosis | cites work | P2860 |
Search more.